“It was a year of madness
”, “
an unprecedented adventure
”, a “time-
lapse film
”… Emmanuelle Quilès chooses her words carefully to describe these last months marked by the health crisis. The climax will undoubtedly have been this week of suspense that she has just experienced. Janssen's vaccine (Johnson & Johnson), of which she heads the French subsidiary, received the green light from the European Medicines Agency on Tuesday. Its deployment was abruptly stopped last week because of six suspected cases of thrombosis when the first deliveries had just been made. A real frustration for the one who had lived for several months at the rate of the advance of the vaccine. "
My job is to ensure that the vaccines are delivered on time to the French authorities who ordered them from us, despite the complexity of the logistics chain
, ”says the manager.
To discover
Covid-19: instructions for use of self-tests
Read also:
The decision-makers of the Janssen laboratory
If she heads the subsidiary of an American group, Emmanuelle Quilès is delighted to have been able to defend the colors of the
This article is for subscribers only.
You have 82% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in
